Kathiresan Sekar
Insider CIK 1864112 · RLAY Director · VERV Chief Executive Officer, Director · MAZE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2025-09-22 | 2025-09-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 500,203 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 488,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 150,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 120,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 99,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 138,995 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 167,425 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 75,105 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 431,988 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 526,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 240,997 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 348,431 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 110,997 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2025-06-06 | 2025-06-06 | 136,681 | — | $0 | 136,681 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2025-04-02 | 2025-04-03 | 9,822 | $4.15 | $40.8K | 346,686 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 33,000 | — | $0 | 99,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2025-04-01 | 2025-04-03 | 33,000 | — | $0 | 356,508 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 120,000 | — | $0 | 120,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 488,000 | — | $0 | 488,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | G Gift | 2024-12-04 | 2024-12-04 | 30,000 | — | $0 | 323,508 | SEC↗ |
| VERV Verve Therapeutics, Inc. | G Gift | 2024-12-04 | 2024-12-04 | 30,000 | — | $0 | 110,997 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2024-06-28 | 2024-07-02 | 30,000 | — | $0 | 215,308 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2024-06-28 | 2024-07-02 | 30,000 | $2.87 | $86.1K | 351,128 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2024-06-03 | 2024-06-05 | 102,225 | — | $0 | 102,225 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 132,000 | — | $0 | 132,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 526,000 | — | $0 | 526,000 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2023-05-31 | 2023-06-01 | 66,055 | — | $0 | 66,055 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2023-02-14 | 2023-02-16 | 550,200 | — | $0 | 550,200 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 50,000 | — | $0 | 138,995 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-03 | 2022-10-05 | 9,904 | $34.97 | $346.3K | 317,839 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-03 | 2022-10-05 | 11,185 | $34.13 | $381.7K | 327,743 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-10-03 | 2022-10-05 | 50,000 | $1.39 | $69.5K | 367,839 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-03 | 2022-10-05 | 28,911 | $33.02 | $954.6K | 338,928 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-08-10 | 2022-08-11 | 50,000 | — | $0 | 167,425 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-08-10 | 2022-08-11 | 50,000 | $29.90 | $1.50M | 317,839 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-08-10 | 2022-08-11 | 50,000 | $1.39 | $69.5K | 367,839 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2022-07-25 | 2022-07-27 | 71,881 | — | $0 | 71,881 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-07-19 | 2022-07-21 | 50,000 | — | $0 | 217,425 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-07-19 | 2022-07-21 | 50,000 | $29.90 | $1.50M | 317,839 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-07-19 | 2022-07-21 | 50,000 | $1.39 | $69.5K | 367,839 | SEC↗ |
| VERV Verve Therapeutics, Inc. | G Gift deriv | 2022-07-12 | 2022-07-15 | 140,000 | — | $0 | 140,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | G Gift deriv | 2022-07-12 | 2022-07-15 | 160,000 | — | $0 | 445,308 | SEC↗ |
| VERV Verve Therapeutics, Inc. | G Gift deriv | 2022-07-12 | 2022-07-15 | 140,000 | — | $0 | 291,988 | SEC↗ |
| VERV Verve Therapeutics, Inc. | G Gift deriv | 2022-07-12 | 2022-07-15 | 160,000 | — | $0 | 300,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | G Gift | 2022-07-07 | 2022-07-15 | 160,000 | — | $0 | 317,839 | SEC↗ |
| VERV Verve Therapeutics, Inc. | G Gift | 2022-07-07 | 2022-07-15 | 160,000 | — | $0 | 240,997 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-03-18 | 2022-03-22 | 69,674 | — | $0 | 605,308 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-03-18 | 2022-03-22 | 69,674 | $2.87 | $200.0K | 477,525 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 332,000 | — | $0 | 332,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-01-04 | 2022-01-06 | 1,870 | — | $0 | 267,425 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 1,870 | $39.90 | $74.6K | 406,536 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-01-04 | 2022-01-06 | 1,870 | $1.39 | $2.6K | 408,406 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2021-12-28 | 2021-12-29 | 6,693 | — | $0 | 269,295 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2021-12-28 | 2021-12-29 | 6,693 | $1.39 | $9.3K | 413,229 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-28 | 2021-12-29 | 6,693 | $39.90 | $267.1K | 406,536 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2021-12-27 | 2021-12-29 | 42,000 | — | $0 | 275,988 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-27 | 2021-12-29 | 4,787 | $41.24 | $197.4K | 407,306 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-27 | 2021-12-29 | 770 | $42.21 | $32.5K | 406,536 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-27 | 2021-12-29 | 36,443 | $40.02 | $1.46M | 412,093 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2021-12-27 | 2021-12-29 | 42,000 | $1.39 | $58.4K | 448,536 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2021-12-23 | 2021-12-27 | 57,000 | — | $0 | 317,988 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2021-12-23 | 2021-12-27 | 57,000 | $1.39 | $79.2K | 463,536 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-23 | 2021-12-27 | 57,000 | $39.90 | $2.27M | 406,536 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2021-12-22 | 2021-12-27 | 57,000 | — | $0 | 374,988 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 16,718 | $38.31 | $640.5K | 440,944 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 31,139 | $39.06 | $1.22M | 409,805 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 5,874 | $37.38 | $219.6K | 457,662 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2021-12-22 | 2021-12-27 | 57,000 | $1.39 | $79.2K | 463,536 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 3,269 | $39.78 | $130.0K | 406,536 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2021-06-21 | 2021-06-21 | 2,500 | $19.00 | $47.5K | 406,536 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 53,998 | — | $0 | 53,998 | SEC↗ |